Please assess the completion status of the following clinical trial:

Trial Title: Paracervical Block During Office Hysteroscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women eligible and scheduled for office hysteroscopic placement of essure devices~Exclusion Criteria:~* Planned secondary procedures~* Lidocaine allergy~* Repeat procedures

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Lidocaine paracervical block (Type: EXPERIMENTAL): 5cc 1% lidocaine injection in each paracervical region
- Saline placebo injection (Type: PLACEBO_COMPARATOR): 5cc Normal Saline injection in each paracervical region

Based on this trial design, predict the completion outcome and termination type (if applicable).